A Molecular Case Series: Deep Cellular and Spatial Epigenetic Characterization of Human Colorectal Cancer
分子案例系列:人类结直肠癌的深层细胞和空间表观遗传特征
基本信息
- 批准号:10677611
- 负责人:
- 金额:$ 4.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:Aberrant DNA MethylationAddressAwarenessBioinformaticsCase SeriesCell divisionCellsCellularityClinicalClonal ExpansionCollaborationsColon CarcinomaColorectalColorectal CancerColorectal NeoplasmsComplexDNA MethylationDNA Modification MethylasesDNA Sequence AlterationDNA mappingDataData SetDepositionDevelopmentDiseaseDoctor of PhilosophyEarly treatmentEnvironmentEpigenetic ProcessEtiologyEventEvolutionExhibitsFrequenciesGene FrequencyGene TargetingGenesGeneticGenetic TranscriptionGoalsGrowthHeterogeneityHistologicHumanHypermethylationImmuneIndividualIntestinal PolypsJointsKnowledgeLaboratoriesLarge Intestine CarcinomaLearningLibrariesLinkMalignant - descriptorMalignant NeoplasmsMeasuresMediatingMedicineMentorshipMethylationMichiganModelingMolecularMucous MembraneMutationNormal tissue morphologyPatternPlayPolycombRecurrenceResearch TrainingResolutionResourcesRoleSamplingScientistSpatial DistributionSystemTechniquesTestingThe Cancer Genome AtlasTimeTissue SampleTissuesTrainingTraining ProgramsTranscriptional RegulationTumor ExpansionUniversitiesWNT Signaling PathwayWorkage relatedbasebisulfite sequencingcancer genomecancer initiationcollegecolorectal cancer progressioncolorectal cancer treatmentdesigndriver mutationexperimental studygenetic variantgenome-widegenomic locushistological specimensinsightmouse modelneoplastic cellpermissivenessprogramspromoterprospectivescreeningsegregationsingle cell analysisstem cellstumortumor progressionwhole genome
项目摘要
PROJECT SUMMARY/ABSTRACT
Cancer has long been thought of as a disease caused by genetic mutations that enable a cell to grow
out of control. However, there is growing awareness of the importance of epigenetic aberrations – disruptions in
the systems that control the transcriptional potential of genes – in cancer initiation and progression. Sufficient
levels of DNA methyltransferase activity, which are responsible for the deposition of DNA methylation (an
important epigenetic mark), have been shown to be necessary for formation of intestinal polyps in mouse models
of colorectal cancer (CRC). Furthermore, hypermethylation of many genetic loci has been noted in CRC tissue
samples. These hypermethylated loci are significantly enriched in genes targeted by the polycomb repressive
complex (Polycomb Target Genes or PTGs), which play important roles in development and differentiation. Thus,
suppression of PTGs by aberrant DNA methylation could contribute to the development and progression of CRC.
However, it is unclear when and where these PTG hypermethylation (PTGH) events arise. They may
arise as a result of genetic mutations, but studies of the cancer genome have failed to find any mutation linked
to PTGH. Also, PTGH events have been found in histologically normal colorectal tissue. Thus, it is possible that
PTGH accumulates over time in normal colorectal tissue, with excessive levels of this mark allowing malignant
transformation. If this is the case, at least some PTGH events should be found clonally (in every cell of a tumor),
because they existed in the founding cell of the tumor. The experiments outlined here are designed to test this
model by constructing a detailed map of DNA methylation in human colorectal tumors and adjacent mucosa.
Specifically, they aim to test the hypotheses that 1) PTGH exists in tumor-adjacent colorectal mucosa in a spatial
and cellular distribution consistent with accumulation over time, and that 2) PTGH events are clonally present
within CRC tumors. To achieve these goals, the proposed studies use bulk and single-cell whole-genome
bisulfite sequencing techniques to measure genome-wide DNA methylation at single-base resolution. These
studies will greatly strengthen our understanding of the cellular and spatial distribution of PTGH in CRC, giving
us a better understanding of when and where this mark arises. Ultimately, these findings could help to develop
more sensitive screening tests or earlier treatments for colorectal cancer.
These studies will be conducted as part of the applicant’s training in a joint MD-PhD program sponsored
by Michigan State University College of Human Medicine and Van Andel Institute (VAI). VAI provides a rich
environment for research training, combining ample scientific resources with opportunities to learn from world-
class scientists in a focused setting. The applicant will receive mentorship from leading experts in the field of
DNA methylation, single-cell analysis, and bioinformatics, as well as many opportunities for collaboration,
professional development, and continued clinical activity throughout the training program.
项目总结/摘要
癌症一直被认为是一种由基因突变引起的疾病,这种突变使细胞能够生长
失控了然而,越来越多的人意识到表观遗传畸变的重要性--
控制基因转录潜能的系统-在癌症的发生和发展中。足够
水平的DNA甲基转移酶活性,这是负责沉积的DNA甲基化(一个
重要表观遗传标记),已经显示对于小鼠模型中肠息肉形成是必需的
结直肠癌(CRC)。此外,在结直肠癌组织中发现了许多基因位点的高甲基化
样品这些高度甲基化的基因座在多梳抑制基因靶向的基因中显著富集,
多梳靶基因(Polycomb Target Genes,PTG)是一种在发育和分化中起重要作用的基因。因此,在本发明中,
通过异常DNA甲基化抑制PTG可能有助于CRC的发生和进展。
然而,目前尚不清楚这些PTG超甲基化(PTGH)事件何时何地发生。他们可能
由于基因突变而产生,但对癌症基因组的研究未能发现任何与癌症有关的突变。
到PTGH。此外,在组织学正常的结直肠组织中也发现了PTGH事件。因此,有可能
PTGH在正常结直肠组织中随着时间的推移而积累,该标志物的过量水平允许恶性肿瘤的发生。
转型如果是这种情况,至少应该在克隆中发现一些PTGH事件(在肿瘤的每个细胞中),
因为它们存在于肿瘤的创始细胞中。这里概述的实验旨在测试这一点
通过构建人类结直肠肿瘤和邻近粘膜中DNA甲基化的详细图谱,
具体来说,他们的目的是检验以下假设:1)PTGH存在于肿瘤邻近的结直肠粘膜中,
细胞分布与随时间累积一致,2)PTGH事件是克隆性存在的
在CRC肿瘤中。为了实现这些目标,拟议的研究使用批量和单细胞全基因组
亚硫酸氢盐测序技术以单碱基分辨率测量全基因组DNA甲基化。这些
研究将大大加强我们对CRC中PTGH细胞和空间分布的了解,给出
让我们更好地了解这个标记何时何地出现。最终,这些发现可能有助于开发
更敏感的筛查测试或早期治疗结直肠癌。
这些研究将作为申请人在联合MD-PhD项目中培训的一部分进行
密歇根州立大学人类医学院和货车安德尔研究所(VAI)。奥钢联提供丰富的
研究培训的环境,将丰富的科学资源与向世界学习的机会相结合,
科学家们在一个集中的环境中。申请人将获得该领域领先专家的指导,
DNA甲基化、单细胞分析和生物信息学,以及许多合作机会,
专业发展,并在整个培训计划中持续开展临床活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathan J. Spix其他文献
High-coverage allele-resolved single-cell DNA methylation profiling reveals cell lineage, X-inactivation state, and replication dynamics
高覆盖率等位基因解析的单细胞 DNA 甲基化分析揭示了细胞谱系、X 染色体失活状态和复制动态
- DOI:
10.1038/s41467-025-61589-1 - 发表时间:
2025-07-08 - 期刊:
- 影响因子:15.700
- 作者:
Nathan J. Spix;Walid Abi Habib;Zhouwei Zhang;Emily Eugster;Hsiao-yun Milliron;David Sokol;KwangHo Lee;Paula A. Nolte;Jamie L. Endicott;Kelly F. Krzyzanowski;Toshinori Hinoue;Jacob Morrison;Benjamin K. Johnson;Wanding Zhou;Hui Shen;Peter W. Laird - 通讯作者:
Peter W. Laird
Nathan J. Spix的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathan J. Spix', 18)}}的其他基金
A Molecular Case Series: Deep Cellular and Spatial Epigenetic Characterization of Human Colorectal Cancer
分子案例系列:人类结直肠癌的深层细胞和空间表观遗传特征
- 批准号:
10537774 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Research Grant